Bioventix PLC (AIM:BVXP)
London
· Delayed Price · Currency is GBP · Price in GBX 1,650.00
-50.00 (-2.94%)
Apr 28, 2026, 5:15 PM GMT
Bioventix Revenue
Bioventix had revenue of 6.16M GBP in the half year ending December 31, 2025, a decrease of -7.74%. This brings the company's revenue in the last twelve months to 12.54M, down -8.21% year-over-year. In the fiscal year ending June 30, 2025, Bioventix had annual revenue of 13.12M, down -3.61%.
Revenue (ttm)
12.54M
Revenue Growth
-8.21%
P/S Ratio
7.08
Revenue / Employee
1.05M
Employees
12
Market Cap
88.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 13.12M | -490.72K | -3.61% |
| Jun 30, 2024 | 13.61M | 790.36K | 6.17% |
| Jun 30, 2023 | 12.82M | 1.10M | 9.36% |
| Jun 30, 2022 | 11.72M | 788.68K | 7.22% |
| Jun 30, 2021 | 10.93M | 617.01K | 5.98% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Faron Pharmaceuticals Oy | 1.14M |
| 4basebio | 1.78M |
| Ondine Biomedical | 1.18M |
| Scancell Holdings | 4.71M |
| hVIVO | 49.66M |
| ImmuPharma | -69.96K |
| PureTech Health | 4.66M |
| SkinBioTherapeutics | 4.64M |
Bioventix News
- 6 months ago - AIM Market Roundup: Angle, Coyngar, Light Science Technologies - The Armchair Trader